ACQUIREDStaleActinium Pharmaceuticals Inc · NASDAQ+753,600 shFiled 4 Sept 2026·SEC Form 4·view source
ACQUIREDStaleActinium Pharmaceuticals Inc · NASDAQ+1,027,274 shFiled 4 Sept 2026·SEC Form 4·view source